Trial Profile
A Randomized, Open and Control Clinical Study of Endostar Injection Concomitant With SOX Protocols in Treating Advanced Gastric Cancer
Status:
Active, no longer recruiting
Phase of Trial:
Phase III
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Endostatin (Primary) ; Gimeracil/oteracil/tegafur; Oxaliplatin
- Indications Gastric cancer
- Focus Therapeutic Use
- 22 Dec 2013 New trial record